133 related articles for article (PubMed ID: 15217837)
21. MLL gene alterations in radiation-associated acute myeloid leukemia.
Klymenko SV; Bink K; Trott KR; Bebeshko VG; Bazyka DA; Dmytrenko IV; Abramenko IV; Bilous NI; Zitzelsberger H; Misurin AV; Atkinson MJ; Rosemann M
Exp Oncol; 2005 Mar; 27(1):71-5. PubMed ID: 15812362
[TBL] [Abstract][Full Text] [Related]
22. Retrovirus-mediated gene transfer of MLL-ELL transforms primary myeloid progenitors and causes acute myeloid leukemias in mice.
Lavau C; Luo RT; Du C; Thirman MJ
Proc Natl Acad Sci U S A; 2000 Sep; 97(20):10984-9. PubMed ID: 10995463
[TBL] [Abstract][Full Text] [Related]
23. Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells.
Kawagoe H; Humphries RK; Blair A; Sutherland HJ; Hogge DE
Leukemia; 1999 May; 13(5):687-98. PubMed ID: 10374871
[TBL] [Abstract][Full Text] [Related]
24. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia.
Armstrong SA; Staunton JE; Silverman LB; Pieters R; den Boer ML; Minden MD; Sallan SE; Lander ES; Golub TR; Korsmeyer SJ
Nat Genet; 2002 Jan; 30(1):41-7. PubMed ID: 11731795
[TBL] [Abstract][Full Text] [Related]
25. Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group.
Gröschel S; Schlenk RF; Engelmann J; Rockova V; Teleanu V; Kühn MW; Eiwen K; Erpelinck C; Havermans M; Lübbert M; Germing U; Schmidt-Wolf IG; Beverloo HB; Schuurhuis GJ; Ossenkoppele GJ; Schlegelberger B; Verdonck LF; Vellenga E; Verhoef G; Vandenberghe P; Pabst T; Bargetzi M; Krauter J; Ganser A; Valk PJ; Löwenberg B; Döhner K; Döhner H; Delwel R
J Clin Oncol; 2013 Jan; 31(1):95-103. PubMed ID: 23008312
[TBL] [Abstract][Full Text] [Related]
26. High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients.
Barjesteh van Waalwijk van Doorn-Khosrovani S; Erpelinck C; van Putten WL; Valk PJ; van der Poel-van de Luytgaarde S; Hack R; Slater R; Smit EM; Beverloo HB; Verhoef G; Verdonck LF; Ossenkoppele GJ; Sonneveld P; de Greef GE; Löwenberg B; Delwel R
Blood; 2003 Feb; 101(3):837-45. PubMed ID: 12393383
[TBL] [Abstract][Full Text] [Related]
27. Analysis of MLL-derived transcripts in infant acute monocytic leukemia with a complex translocation (1;11;4)(q21;q23;p16).
So CW; Ma SK; Wan TS; Chan GC; Ha SY; Chan LC
Cancer Genet Cytogenet; 2000 Feb; 117(1):24-7. PubMed ID: 10700861
[TBL] [Abstract][Full Text] [Related]
28. Internal tandem duplications of the FLT3 and MLL genes are mainly observed in atypical cases of therapy-related acute myeloid leukemia with a normal karyotype and are unrelated to type of previous therapy.
Christiansen DH; Pedersen-Bjergaard J
Leukemia; 2001 Dec; 15(12):1848-51. PubMed ID: 11753604
[TBL] [Abstract][Full Text] [Related]
29. FLT3 and MLL intragenic abnormalities in AML reflect a common category of genotoxic stress.
Libura M; Asnafi V; Tu A; Delabesse E; Tigaud I; Cymbalista F; Bennaceur-Griscelli A; Villarese P; Solbu G; Hagemeijer A; Beldjord K; Hermine O; Macintyre E
Blood; 2003 Sep; 102(6):2198-204. PubMed ID: 12791658
[TBL] [Abstract][Full Text] [Related]
30. FLT3 mutations are associated with other molecular lesions in AML.
Carnicer MJ; Nomdedéu JF; Lasa A; Estivill C; Brunet S; Aventín A; Sierra J
Leuk Res; 2004 Jan; 28(1):19-23. PubMed ID: 14630076
[TBL] [Abstract][Full Text] [Related]
31. Detection of leukemia-associated MLL-GAS7 translocation early during chemotherapy with DNA topoisomerase II inhibitors.
Megonigal MD; Cheung NK; Rappaport EF; Nowell PC; Wilson RB; Jones DH; Addya K; Leonard DG; Kushner BH; Williams TM; Lange BJ; Felix CA
Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2814-9. PubMed ID: 10706619
[TBL] [Abstract][Full Text] [Related]
32. MIR29B regulates expression of MLLT11 (AF1Q), an MLL fusion partner, and low MIR29B expression associates with adverse cytogenetics and poor overall survival in AML.
Xiong Y; Li Z; Ji M; Tan AC; Bemis J; Tse JV; Huang G; Park J; Ji C; Chen J; Bemis LT; Bunting KD; Tse W
Br J Haematol; 2011 Jun; 153(6):753-7. PubMed ID: 21496004
[TBL] [Abstract][Full Text] [Related]
33. High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.
Laszlo GS; Alonzo TA; Gudgeon CJ; Harrington KH; Kentsis A; Gerbing RB; Wang YC; Ries RE; Raimondi SC; Hirsch BA; Gamis AS; Meshinchi S; Walter RB
J Hematol Oncol; 2015 Oct; 8():115. PubMed ID: 26487643
[TBL] [Abstract][Full Text] [Related]
34. Detection of unique ALL1 (MLL) fusion transcripts in normal human bone marrow and blood: distinct origin of normal versus leukemic ALL1 fusion transcripts.
Marcucci G; Strout MP; Bloomfield CD; Caligiuri MA
Cancer Res; 1998 Feb; 58(4):790-3. PubMed ID: 9485036
[TBL] [Abstract][Full Text] [Related]
35. Dimerization of MLL fusion proteins and FLT3 activation synergize to induce multiple-lineage leukemogenesis.
Ono R; Nakajima H; Ozaki K; Kumagai H; Kawashima T; Taki T; Kitamura T; Hayashi Y; Nosaka T
J Clin Invest; 2005 Apr; 115(4):919-29. PubMed ID: 15761502
[TBL] [Abstract][Full Text] [Related]
36. Infant acute lymphoblastic leukemia with MLL gene rearrangements: outcome following intensive chemotherapy and hematopoietic stem cell transplantation.
Kosaka Y; Koh K; Kinukawa N; Wakazono Y; Isoyama K; Oda T; Hayashi Y; Ohta S; Moritake H; Oda M; Nagatoshi Y; Kigasawa H; Ishida Y; Ohara A; Hanada R; Sako M; Sato T; Mizutani S; Horibe K; Ishii E
Blood; 2004 Dec; 104(12):3527-34. PubMed ID: 15297313
[TBL] [Abstract][Full Text] [Related]
37. Acute myeloid leukemia with hypergranular cytoplasm accompanied by t(X;11)(q24;q23) and rearrangement of the MLL gene.
Nakata Y; Mori T; Yamazaki T; Suzuki T; Okazaki T; Kurosawa Y; Kinoshita A; Ohyashiki K; Nakazawa S
Leuk Res; 1999 Jan; 23(1):85-8. PubMed ID: 9933140
[TBL] [Abstract][Full Text] [Related]
38. Cellular drug sensitivity in MLL-rearranged childhood acute leukaemia is correlated to partner genes and cell lineage.
Palle J; Frost BM; Forestier E; Gustafsson G; Nygren P; Hellebostad M; Jonsson OG; Kanerva J; Schmiegelow K; Larsson R; Lönnerholm G;
Br J Haematol; 2005 Apr; 129(2):189-98. PubMed ID: 15813846
[TBL] [Abstract][Full Text] [Related]
39. Delineation and molecular characterization of acute myeloid leukemia patients with coduplication of FLT3 and MLL.
Olesen LH; Nyvold CG; Aggerholm A; Nørgaard JM; Guldberg P; Hokland P
Eur J Haematol; 2005 Sep; 75(3):185-92. PubMed ID: 16104873
[TBL] [Abstract][Full Text] [Related]
40. Biological characteristics and prognosis of adult acute myeloid leukemia with internal tandem duplications in the Flt3 gene.
Rombouts WJ; Blokland I; Löwenberg B; Ploemacher RE
Leukemia; 2000 Apr; 14(4):675-83. PubMed ID: 10764154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
